Foreign producers argue India is discouraging innovation by weakening patents, reducing the incentive for big companies to invest time and money to discover drugs.
Mutual funds are so appealing because small-time savers who invest their nest-eggs directly in the stockmarket discover that stockbroking commissions quickly become prohibitive, that diversifying their portfolios efficiently is hard, and that the search for good investments takes up a lot of time.